Becton, Dickinson and Company (BDX) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Franklin Lakes, NJ, United States. Der aktuelle CEO ist Thomas E. Polen Jr..
BDX hat IPO-Datum 1973-02-21, 70,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $56.42B.
Becton, Dickinson and Company is a global medical technology manufacturer founded in 1897 that develops and sells medical supplies, devices, laboratory equipment, and diagnostic products serving healthcare institutions, physicians, life science researchers, clinical laboratories, and pharmaceutical companies worldwide. The company operates through three primary segments: BD Medical, which provides infusion therapy systems, medication management solutions, and diabetes care products; BD Life Sciences, which offers blood collection, microbiology automation, and cellular analysis systems; and BD Interventional, which supplies surgical instruments, grafts, and critical care products. With headquarters in Franklin Lakes, New Jersey, the company delivers comprehensive solutions across medical device manufacturing, laboratory diagnostics, and clinical interventions.
